Lead author Kenneth Tsang from the LKS Faculty of Medicine, The University of Hong Kong said, ‘not as symptoms of bronchiectasis are specific, many patients are misdiagnosed as patients with other inflammatory diseases of the airways such as asthma and COPD, despite frequent in Asia Pacific, remains bronchiectasis a neglected disease that more research attention for better understanding of the etiology, Pathogenesis and treatmentnt should be given. ‘.. The first paper entitled ‘Clinical challenges in managing bronchiectasis ‘provides an overview of the characteristics and clinical features of bronchiectasis.
###About VentracorVentracor is a global medical device company that has developed a blood pump VentrAssist left ventricular assist device in patients with heart failure.Present the preparation of putrescin an industrial scale by chemical synthesis, the non-renewable petrochemicals and pricey catalyst system as requires. E. Coli strain is highly poisonous and combustible with potentially serious effects on the environment and human health. Now, the Korean-based team being has led led by Professor singing Yup Lee at KAIST significantly to the biotechnological production of the chemical with renewable resources. – is the first time we have an of metabolically E. Coli strain, which has developed effective produce putrescine, said Professor Lee. The development of a bio-refinery for chemicals and materials is very important to in a world that be in the dependent on fossil fuels a growing concern. .
Our team of South Korean researchers in engineering science the bacterium E. Coli has succeeded producing the industrial chemical putrescin. That research, published in the journal Biotechnology and Bioengineering is a of renewable alternative to produce this key chemistry using with tradition fossil fuels.